Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

UBS ETRACS INVESTOR ALERT- Notice from Levin Law, P.A. to Investors Who Purchased UBS ETRACS Notes

Levin Law, P.A. is investigating UBS Financial Services Inc. and other brokerage firms regarding losses in UBS ETRACS ETNs bearing the ticker symbols LBDC, MORL, MRRL, LRET, MLPQ, HOML, MLPZ, LMLP, WTID, HDLV, SMHD, DVHL, CEFL, CEFZ, BDCL


News provided by

Levin Law, P.A.

Apr 06, 2020, 08:00 ET

Share this article

Share toX

Share this article

Share toX


MIAMI, Fla., April 6, 2020 /PRNewswire-PRWeb/ -- The national securities law firm, Levin Law, P.A. ("Levin Law") (http://www.levinlawpa.com) announced today that it is investigating UBS Financial Services Inc. ("UBS") and other brokerage firms regarding losses stemming from the recommendation and sale of certain UBS ETRACS exchange-traded notes ("ETNs") that are supposed to track different market indexes. The ticket symbols of the ETRACS ETNs that might have been impacted include: LBDC, MORL, MRRL, LRET, MLPQ, HOML, MLPZ, LMLP, WTID, HDLV, SMHD, DVHL, CEFL, CEFZ, BDCL.

Levin Law is investigating whether brokerage firms that sold UBS ETRACS ETNs fully and accurately disclosed all material risks of the UBS ETRACS ETNs prior to recommending and selling such investments to their customers. Brokerage firms that did not fully and accurately describe the material risks and benefits of the ETRACS ETNs or engaged in other wrongdoing regarding UBS ETRACS ETNs may be liable for investors' losses.

"Brokerage firms that did not fully and accurately describe the material risks and benefits of the ETRACS ETNs or engaged in other wrongdoing regarding UBS ETRACS ETNs may be liable for investors’ losses."

Post this

UBS ETRACS ETNs are risky and complex investments. ETRACS ETNs are senior, unsecured, unsubordinated debt securities that are designed to track the total return of a specific market index. UBS ETRACS ETNs are risky and leveraged products that can cause massive investment losses and are unsuitable for many investors, including risk-averse retirees, investors seeking stable, fixed income returns, and investors seeking to preserve their principal.

Due in part to the spread of COVID-19, the global securities markets have dropped precipitously. As a result, UBS has instituted mandatory redemptions of certain ETRACS ETNs and has frozen the trading of other ETRACS ETNs. Many ETRACS ETNs investors have lost a substantial percentage of the money that they invested in ETRACS ETNs.

The UBS ETRACS ETNs that may have been impacted include, but are not limited to:

  •     BDCL 2x Leveraged Long Wells Fargo Business Development Company Index
  •     BDCY 2x Leveraged Long Wells Fargo Business Development Company Index
  •     CEFL 2x Leveraged Closed-End Fund
  •     CEFZ 2x Leveraged Closed-End Fund
  •     DVHL 2x Leveraged Diversified High Income
  •     DVYL 2x Leveraged Dow Jones Select Dividend Index
  •     HDLB 2x Leveraged U.S. High Dividend Low Volatility
  •     HOML 2x Leveraged ISE Exclusively Homebuilders
  •     LBDC 2x Leveraged Long Wells Fargo Business Development Company
  •     LMLB 2x Leveraged Wells Fargo MLP Ex-Energy
  •     LRET 2x Leveraged MSCI US REIT Index
  •     MLPQ 2x Monthly Leveraged Alerian MLP Infrastructure Index
  •     MLPZ 2x Monthly Leveraged S&P MLP Index
  •     MORL 2x Leveraged Mortgage REIT
  •     MRRL 2x Leveraged Mortgage REIT
  •     SDYL 2x Leveraged S&P Dividend
  •     SMHB 2x Leveraged US Small Cap High Dividend
  •     SMHD 2x Leveraged US Small Cap High Dividend
  •     WTID 3x Inverse Crude ETN linked to the Bloomberg WTI Crude Oil sub index

If your financial advisor, broker, or other investment professional recommended that you purchase UBS ETRACS ETNs and you have lost money in those investments, you may be able to recover your losses through a Financial Industry Regulatory Authority ("FINRA") arbitration claim.

If you have information about the sales practices of any brokerage firm that recommended or sold UBS ETRACS ETNs or believe that you have suffered losses in UBS ETRACS ETNs, please contact Levin Law managing partner, Brian Levin, at 305-402-9050, [email protected], or visit Levin Law's website, https://www.levinlawpa.com. For more information about pursuing an arbitration claim for your UBS ETRACS losses, please visit https://www.levinlawpa.com/lp-ubs-etrac/.

About Levin Law: Levin Law is a premier national securities and class action law firm with significant experience. Brian Levin, Levin Law's founding attorney, has helped recover approximately $100,000,000 through securities arbitration and litigation for individual and institutional investors throughout the country and the rest of the world. Levin Law represents retirees, individual investors, high-net-worth investors, ultra-high-net-worth investors, institutions, family offices, trusts, publicly held companies, and others. Levin Law is based in Miami, has additional offices in Michigan and California, and practices nationwide and represents investors throughout the world.

Contact:
Levin Law, P.A.
Brian Levin, Esq.
305-402-9050
[email protected]
http://www.levinlawpa.com

SOURCE Levin Law, P.A.

Related Links

http://www.levinlawpa.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.